相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Peroxisomal alterations in Alzheimer's disease
Jianqiu Kou et al.
ACTA NEUROPATHOLOGICA (2011)
Mass and relative elution time profiling: two-dimensional analysis of sphingolipids in Alzheimer's disease brains
Leila Hejazi et al.
BIOCHEMICAL JOURNAL (2011)
Phytanic acid metabolism in health and disease
Ronald J. A. Wanders et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2011)
Plasmalogens the neglected regulatory and scavenging lipid species
Stefan Wallner et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2011)
Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease
Marcus O. W. Grimm et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Linking lipids to Alzheimer's disease: cholesterol and beyond
Gilbert Di Paolo et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics
Xianlin Han et al.
PLOS ONE (2011)
Towards a whole-body systems [multi-organ] lipidomics in Alzheimer's disease
Giuseppe Astarita et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2011)
Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss
Michelle M. Mielke et al.
ALZHEIMERS & DEMENTIA (2010)
Phospholipase A2 and arachidonic acid in Alzheimer's disease
Rene O. Sanchez-Mejia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Plasma metabolic profiling of Alzheimer's disease by liquid chromatography/mass spectrometry
Nai-jing Li et al.
CLINICAL BIOCHEMISTRY (2010)
Circulating plasmalogen levels and Alzheimer Disease Assessment Scale-Cognitive scores in Alzheimer patients
Paul L. Wood et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2010)
Studies on Plasmalogen-Selective Phospholipase A2 in Brain
Akhlaq A. Farooqui
MOLECULAR NEUROBIOLOGY (2010)
Membrane plasmalogen composition and cellular cholesterol regulation: a structure activity study
Rishikesh Mankidy et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Deregulation of sphingolipid metabolism in Alzheimer's disease
Xingxuan He et al.
NEUROBIOLOGY OF AGING (2010)
Deficient Liver Biosynthesis of Docosahexaenoic Acid Correlates with Cognitive Impairment in Alzheimer's Disease
Giuseppe Astarita et al.
PLOS ONE (2010)
Docosahexaenoic acid neurolipidomics
Tiffany D. Niemoller et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2010)
The essential role of lipids in Alzheimer's disease
Sabrina Florent-Bechard et al.
BIOCHIMIE (2009)
Cerebrospinal Fluid Secretory Ca2+-Dependent Phospholipase A2 Activity Is Increased in Alzheimer Disease
Sonia Chalbot et al.
CLINICAL CHEMISTRY (2009)
Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease
Charalampos Dragonas et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis
N. H. Stricker et al.
NEUROIMAGE (2009)
Factors associated with resistance to dementia despite high Alzheimer disease pathology
D. Erten-Lyons et al.
NEUROLOGY (2009)
Top-Down Lipidomics Reveals Ether Lipid Deficiency in Blood Plasma of Hypertensive Patients
Juergen Graessler et al.
PLOS ONE (2009)
Physiological Pathway for Low-Density Lipoproteins across the Blood-Brain Barrier: Transcytosis through Brain Capillary Endothelial Cells In Vitro
Pietra Candela et al.
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2008)
Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementia
Stefan Smesny et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
Fatty acid binding protein: Localization and functional significance in the brain
Yuji Owada
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Exosomal transfer of proteins and RNAs at synapses in the nervous system
Neil R. Smalheiser
BIOLOGY DIRECT (2007)
Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia
Dayan B. Goodenowe et al.
JOURNAL OF LIPID RESEARCH (2007)
Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: A shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?
Pavel Katsel et al.
NEUROCHEMICAL RESEARCH (2007)
Effect of docosahexaenoic acid on tissue targeting and metabolism of plasma lipoproteins
Alla Polozova et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2006)
Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease
Shirley W. Y. Tsang et al.
NEUROBIOLOGY OF AGING (2006)
Astroglial expression of ceramide in Alzheimer's disease brains: A role during neuronal apoptosis
H Satoi et al.
NEUROSCIENCE (2005)
Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease
RG Cutler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Elevation of the level and activity of acid ceramidase in Alzheimer's disease brain
Y Huang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients
A Walter et al.
NEUROBIOLOGY OF AGING (2004)
Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline
DS Wang et al.
NEUROSCIENCE RESEARCH (2004)
Impaired axonal transport of cortical neurons in Alzheimer's disease is associated with neuropathological changes
JP Dai et al.
BRAIN RESEARCH (2002)
Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis
XL Han et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Decreased concentrations of serum phospholipid plasmalogens indicate oxidative burden of uraemic patients undergoing hasmodialysis
T Brosche et al.
NEPHRON (2002)
Decreased brain levels of 2′,3′-cyclic nucleotide-3′-phosphodiesterase in Down syndrome and Alzheimer's disease
R Vlkolinsky et al.
NEUROBIOLOGY OF AGING (2001)
Plasmalogen levels in serum from patients with impaired carbohydrate or lipid metabolism and in elderly subjects with normal metabolic values
T Brosche
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2001)
Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry
XL Han et al.
JOURNAL OF NEUROCHEMISTRY (2001)
分享论文
